National Institute of Environmental Health Sciences; Notice of Closed Meeting, 8944 [2017-02159]
Download as PDF
8944
Federal Register / Vol. 82, No. 20 / Wednesday, February 1, 2017 / Notices
Contact Person: Darryl C. Zeldin, Scientific
Director & Principal Investigator, Division of
Intramural Research, National Institute of
Environmental Health Sciences, NIH, 111
T.W. Alexander Drive, Mail drop A2–09,
Research Triangle Park, NC 27709, 919–541–
1169, zeldin@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: January 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02155 Filed 1–31–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel, ‘‘Pricing and Payment Strategies for
Cancer Drugs: Maximizing Patients’ Access to
Beneficial Therapies’’.
Date: March 27, 2017.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: Welcome and Introductions;
Opening Presentations; The Pricing
Landscape; Public Comment; Potential
Actions To Encourage Pricing Strategies That
Maximize Patients’ Access to Drug Therapy;
The Payment Landscape; Wrap-Up and Final
Remarks for the Day; Public Comment.
Place: Kimpton Hotel Palomar, 117 South
17th Street, Philadelphia, PA 19103.
Date: March 28, 2017.
Time: 9:00 a.m. to 1:00 p.m.
VerDate Sep<11>2014
16:23 Jan 31, 2017
Jkt 241001
Agenda: Welcome and Introductions; Day
1 Recap and Continuing Discussion on The
Payment Landscape; Potential Actions To
Encourage Payment Strategies That Maximize
Patients’ Access to Drug Therapy;
Conclusions and Cross-Cutting
Recommendations; Wrap-Up and Next Steps;
Public Comment.
Place: Kimpton Hotel Palomar, 117 South
17th Street, Philadelphia, PA 19103.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, President’s Cancer
Panel, Special Assistant to the Director, Rare
Tumors Initiative, Center for Cancer
Research, National Cancer Institute, NIH,
9000 Rockville Pike, Building 31, Room
B2B37, MSC 2590, Bethesda, MD 20892–
8349, 301–451–9399, sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
prescancerpanel.cancer.gov/, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 26, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel National Toxicology Program
(NTP) Studies to Evaluate Test Agents.
Date: February 16, 2017.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Sheraton Imperial Hotel &
Convention Center 4700 Emperor Blvd.,
Durham, NC 27703.
Contact Person: RoseAnne M. McGee,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30
Research Triangle Park, NC 27709, (919) 541–
0752, mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: January 25, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02159 Filed 1–31–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–02156 Filed 1–31–17; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Neuroscience.
Date: February 23–24, 2017.
Time: 8:00 a.m. to 6:00 p.m.
E:\FR\FM\01FEN1.SGM
01FEN1
Agencies
[Federal Register Volume 82, Number 20 (Wednesday, February 1, 2017)]
[Notices]
[Page 8944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02159]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Environmental Health Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel National Toxicology Program (NTP)
Studies to Evaluate Test Agents.
Date: February 16, 2017.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: Sheraton Imperial Hotel & Convention Center 4700 Emperor
Blvd., Durham, NC 27703.
Contact Person: RoseAnne M. McGee, Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental Health Sciences, P.O. Box
12233, MD EC-30 Research Triangle Park, NC 27709, (919) 541-0752,
mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk Estimation--Health Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic
Research and Education; 93.894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research
and Testing, National Institutes of Health, HHS)
Dated: January 25, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02159 Filed 1-31-17; 8:45 am]
BILLING CODE 4140-01-P